https://www.selleckchem.com/pr....oducts/trastuzumab-d
Background This study aimed to investigate the prognostic value of tumor marker index (TMI) based on preoperative cytokeratin 19 fragment (CYFRA 21-1) and squamous cell carcinoma antigen (SCC-Ag) and the relationship between preoperative TMI and treatment effectiveness of postoperative adjuvant chemotherapy for patients with esophageal squamous cell carcinoma (ESCC). Patients and methods Between January 2009 and December 2014, a total of 267 patients with ESCC who underwent radical resection were retrospectively enrolled.
Me gusta
Comentario
Compartir
